IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2018

Our ACE in the HOLE: Justifying the Use of Angiotensin-converting Enzyme Inhibitors as Adjuvants to Standard Chemotherapy. D.P. RADIN, A. KREBS, A. MAQSUDLU, P. PATEL (Stony Brook; New York, NY; Boston, MA, USA). Anticancer Res 38: 45-49, 2018.
Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect? C. DAMASKOS, I. TOMOS, N. GARMPIS, A. KARAKATSANI, D. DIMITROULIS, A. GARMPI, E. SPARTALIS, C.F. KAMPOLIS, E. TSAGKARI, A.A. LOUKERI, G.-A. MARGONIS, M. SPARTALIS, N. ANDREATOS, D. SCHIZAS, S. KOKKINELI, E.A. ANTONIOU, A. NONNI, G. TSOUROUFLIS, K. MARKATOS, K. KONTZOGLOU, A. KOSTAKIS, P. TOMOS (Athens, Greece; Baltimore, ML, USA). Anticancer Res 38: 37-43, 2018.
Managing Focal Nodular Hyperplasia of the Liver: Surgery or Minimally-invasive Approaches? A Review of the Preferable Treatment Options. E. VIRGILIO, M. CAVALLINI (Rome, Italy). Anticancer Res 38: 33-36, 2018.
Should Adjuvant Radiation Therapy Be Systematically Proposed for Male Breast Cancer? A Systematic Review. P. JARDEL, S. VIGNOT, B. CUTULI, A. CREISSON, S. VASS, E. BARRANGER, J. THARIAT (Saguenay, QC, Canada; Le Coudray; Reims; Nice; Caen, France). Anticancer Res 38: 23-31, 2018.
Regimens of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer. K. MURONO, K. KAWAI, K. HATA, S. EMOTO, M. KANEKO, K. SASAKI, T. NISHIKAWA, K. OTANI, T. TANAKA, H. NOZAWA (Tokyo, Japan). Anticancer Res 38: 15-22, 2018.
The Role of Prophylactic Cranial Irradiation for Non-small Cell Lung Cancer. C. PRECIVAL, M. LANDY, C. POOLE, L. MULLANEY (Dublin, Ireland). Anticancer Res 38: 7-14, 2018.
Cancer Progenitor Cells: The Result of An Epigenetic Event? K. LAPINSKA, G. FARIA, S. MCGONAGLE, K.M. MACUMBER, S. HEERBOTH, S. SARKAR (North Haven, CT; Wellesley; Quincy; Boston, MA; Nashville, TN, USA). Anticancer Res 38: 1-6, 2018.
Microsatellite Instability as a Prognostic Factor in Stage II Colon Cancer Patients, a Meta-Analysis of Published Literature. I. GKEKAS, J. NOVOTNY, L. PECEN, K. STRIGÅRD, R. PALMQVIST, U. GUNNARSSON (Umea; Lulea, Sweden; Prague, Czech Republic). Anticancer Res 37: 6563-6574, 2017.
The “Yin and Yang” of Platelet-rich Plasma in Breast Reconstruction After Mastectomy or Lumpectomy for Breast Cancer. E. SPARTALIS, D.I. TSILIMIGRAS, P. CHARALAMPOUDIS, G.-S. KARACHALIOU, D. MORIS, A. ATHANASIOU, M. SPARTALIS, V. BOLKAS, D. DIMITROULIS, N. NIKITEAS (Athens, Greece; London; Birmingham, UK; Columbus, OH, USA). Anticancer Res 37: 6557-6562, 2017.
Risk Factors for Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation in Malignancies: Proposal for Classification. M. DZIEDZIC, I. SADOWSKA-KRAWCZENKO, J. STYCZYNSKI (Bydgoszcz, Poland). Anticancer Res 37: 6551-6556, 2017.
Clinical, Histopathological and Cytogenetic Prognosticators in Uveal Melanoma – A Comprehensive Review. T. BERUS, A. HALON, A. MARKIEWICZ, J. ORLOWSKA-HEITZMAN, B. ROMANOWSKA-DIXON, P. DONIZY (Wroclaw; Krakow, Poland). Anticancer Res 37: 6541-6549, 2017
The Role of the Androgen Receptor Signaling in Breast Malignancies. P.F. CHRISTOPOULOS, N.I. VLACHOGIANNIS, C.T. VOGKOU, M. KOUTSILIERIS (Athens, Greece). Anticancer Res 37: 6533-6540, 2017.
18F-Fdg-PET-guided Planning and Re-Planning (Adaptive) Radiotherapy in Head and Neck Cancer: Current State of Art. E. FARINA, M. FERIOLI, P. CASTELLUCCI, A. FARINA, G. ZANIRATO RAMBALDI, S. CILLA, S. CAMMELLI, S. FANTI, A.G. MORGANTI (Bologna; Campobasso, Italy). Anticancer Res 37: 6523-6532, 2017.
MiRNA-210: A Current Overview. A. BAVELLONI, G. RAMAZZOTTI, A. POLI, M. PIAZZI, E. FOCACCIA, W. BLALOCK, I. FAENZA (Bologna; Milan, Italy). Anticancer Res 37: 6511-6521, 2017.
Optimising Selenium for Modulation of Cancer Treatments. S.O. EVANS, P.F. KHAIRUDDIN, M.B. JAMESON (Hamilton, New Zealand). Anticancer Res 37: 6497-6509, 2017.
Lipofilling Outcomes Mimicking Breast Cancer Recurrence: Case Report and Update of the Literature. S. GIGLI, M.I. AMABILE, F. DI PASTENA, A. DE LUCA, C. GULIA, L. MANGANARO, M. MONTI, L. BALLESIO (Rome, Italy). Anticancer Res 37: 5395-5398, 2017.
The Role of Toll Like Receptors (TLRs) in Oral Carcinogenesis. L. PELLEGRINI PISANI, D. ESTADELLA, D.A. RIBEIRO (Santos, SP, Brazil). Anticancer Res 37: 5389-5394, 2017.
Do Dental X-Rays Induce Genotoxicity and Cytotoxicity in Oral Mucosa Cells? A Critical Review. F. ANGELIERI, V. QUISPE YUJRA, C.T.F. OSHIMA, D.A. RIBEIRO (Sao Paulo, Brazil). Anticancer Res 37: 5383-5388, 2017.
Mitochondrial Dysfunction and Redox Imbalance as a Diagnostic Marker of “Free Radical Diseases”. E. GEORGIEVA, D. IVANOVA, Z. ZHELEV, R. BAKALOVA, M. GULUBOVA, I. AOKI (Stara Zagora; Sofia, Bulgaria; Chiba, Japan). Anticancer Res 37: 5373-5381, 2017.
Clinical Potential of Statins in Prostate Cancer Radiation Therapy. J. HUTCHINSON, L. MARIGNOL (Dublin, Ireland). Anticancer Res 37: 5363-5372, 2017.
Targeting Histone Deacetylases in Malignant Melanoma: A Future Therapeutic Agent or Just Great Expectations? N. GARMPIS, C. DAMASKOS, A. GARMPI, D. DIMITROULIS, E. SPARTALIS, G.-A. MARGONIS, D. SCHIZAS, I. DESKOU, C. DOULA, E. MAGKOUTI, N. ANDREATOS, E.A. ANTONIOU, A. NONNI, K. KONTZOGLOU, D. MANTAS (Athens, Greece; Baltimore, MD, USA; Nicosia, Cyprus). Anticancer Res 37: 5355-5362, 2017.
Topical Management of Acute Radiation Dermatitis in Breast Cancer Patients: A Systematic Review and Meta-Analysis. F. HARUNA, A. LIPSETT, L. MARIGNOL (Dublin, Ireland). Anticancer Res 37: 5343-5353, 2017.
Adjuvant Endocrine Therapy for Hormone-positive Breast Cancer, Focusing on Ovarian Suppression and Extended Treatment: An Update. D. GLASSMAN, S. HIGNETT, S. REHMAN, R. LINFORTH, M. SALHAB (Bradford, UK). Anticancer Res 37: 5329-5341, 2017.
Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma. A. NÄSMAN, C. BERSANI, D. LINDQUIST, J. DU, T. RAMQVIST, T. DALIANIS (Stockholm; Umeå, Sweden). Anticancer Res 37: 5319-5328, 2017.
Anticancer Activity of Artemisinin and its Derivatives. S. SLEZAKOVA, J. RUDA-KUCEROVA (Brno, Czech Republic). Anticancer Res 37:5995-6003, 2017.
Possible Biological and Clinical Applications of Phenothiazines. B. VARGA, Á. CSONKA, A. CSONKA, J. MOLNÁR, L. AMARAL, G. SPENGLER (Szeged, Hungary; Lisbon, Portugal). Anticancer Res 37:5983-5993, 2017.
Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment. B.N. HO, C.M. PFEFFER, A.T.K. SINGH (Kenosha, WI, USA). Anticancer Res 37:5975-5981, 2017.
Perioperative Administration of Traditional Japanese Herbal Medicine Daikenchuto Relieves Postoperative Ileus in Patients Undergoing Surgery for Gastrointestinal Cancer: A Systematic Review and Meta-analysis. M. ISHIZUKA, N. SHIBUYA, H. NAGATA, K. TAKAGI, Y. IWASAKI, H. HACHIYA, T. AOKI, K. KUBOTA (Tochigi, Japan). Anticancer Res 37:5967-5974, 2017.
Immune Checkpoint Inhibitors in Gynecological Cancers: Update of Literature and Perspectives of Clinical Research. A. GADDUCCI, M.E. GUERRIERI (Pisa, Italy). Anticancer Res 37:5955-5965, 2017.
New Drug Combination Strategies in Melanoma: Current Status and Future Directions. A. NAJEM, M. KRAYEM, A. PERDRIX, J. KERGER, A. AWADA, F. JOURNE, G. GHANEM (Brussels; Mons, Belgium; Rouen, France). Anticancer Res 37:5941-5953, 20
Monoclonal Antibodies for the Treatment of Cancer. J.T. PENTO (Oklahoma, OK, USA). Anticancer Res 37:5935-5939, 2017.
A Systematic Review and Meta-analysis of Retrospective Series of Regorafenib for Treatment of Metastatic Colorectal Cancer. J. MERCIER, I.A. VOUTSADAKIS (Sudbury; Sault Ste Marie, ON, Canada). Anticancer Res 37:5925-5934, 2017.
Search for New Type of Anticancer Drugs with High Tumor Specificity and Less Keratinocyte Toxicity. Y. SUGITA, K. TAKAO, Y. UESAWA, H. SAKAGAMI (Sakado; Tokyo, Japan). Anticancer Res 37:5919-5924, 2017.
Therapeutic Innovations for Targeting Childhood Neuroblastoma: Implications of the Neurokinin-1 Receptor System. M. BERGER, D. VON SCHWEINITZ (Munich, Germany). Anticancer Res 37:5911-5918, 2017.
Fluoride Induces Apoptosis in Mammalian Cells: In Vitro and In Vivo Studies. D.A. RIBEIRO, C.M. CARDOSO, V.Q. YUJRA, M.D.B. VIANA, O. AGUIAR JR, L.P. PISANI, C.T.F. OSHIMA (Sao Paulo, Brazil). Anticancer Res 37:4767-4778, 2017.
Colorectal Carcinogenesis: Role of Oxidative Stress and Antioxidants. F. CARINI, M. MAZZOLA, F. RAPPA, A. JURJUS, A.G. GEAGEA, S. AL KATTAR, T. BOU-ASSI, R. JURJUS, P. DAMIANI, A. LEONE, G. TOMASELLO (Palermo, Italy; Beirut; Jal El Dib, Lebanon; Washington, DC, USA). Anticancer Res 37:4759-4766, 2017.
Deepening a Simple Question: Can MSCs Be Used to Treat Cancer? J.P.A. GOMES, A.F. ASSONI, M. PELATTI, G. COATTI, O.K. OKAMOTO, M. ZATZ (Sao Paulo, Brazil). Anticancer Res 37:4747-4758, 2017.
Physical Needs of Long-term Cancer Patients. P. TRALONGO, M.G. PESCARENICO, A. SURBONE, S. BORDONARO, M. BERRETTA, A. DI MARI (Syracuse; Parma; Aviano, Italy; New York, NY, USA). Anticancer Res 37:4733-4746, 2017.
Lidocaine Stimulates the Function of Natural Killer Cells in Different Experimental Settings. J.P. CATA, M.F. RAMIREZ, J.F. VELASQUEZ, A. DI, K.U. POPAT, V. GOTTUMUKKALA, D.M. BLACK, V.O. LEWIS, J.N. VAUTHEY (Houston; Temple, TX; Boston, MA, U.S.A.; Medellin, Colombia). Anticancer Res 37:4727-4732, 2017.
Thrombocytosis Portends Adverse Prognosis in Colorectal Cancer: A Meta-Analysis of 5,619 Patients in 16 Individual Studies. D. GU, A. SZALLASI (Livingston, NJ; Jacksonville, FL, USA). Anticancer Res 37:4717-4726, 2017.
Impact of Parental Cancer on Children. B.K. SHAH, J. ARMALY, E. SWIETER (Sedro-Woolley; Yakima, WA, USA). Anticancer Res 37:4025-4028, 2017.
Genotoxicity Induced by Dental Materials: A Comprehensive Review. D.A. RIBEIRO, V.Q. YUJRA, C.F.G. DE MOURA, B.A. HANDAN, M.D.B. VIANA, L.Y. YAMAUCHI, P.M. CASTELO, O. AGUIAR JR (Sao Paolo, Brazil). Anticancer Res 37:4017-4024, 2017.
Lower Body Lymphedema in Patients with Gynecologic Cancer. N. BIGLIA, V. ZANFAGNIN, A. DANIELE, E. ROBBA, V.E. BOUNOUS (Turin, Italy). Anticancer Res 37:4005-4016, 2017.
Vitamin D Receptor Polymorphism and Cancer: An Update. V. RAI, J. ABDO, S. AGRAWAL, D.K. AGRAWAL (Omaha, NE, USA). Anticancer Res 37:3991-4004, 2017.
BDNF: An Oncogene or Tumor Suppressor? D.P. RADIN, P. PATEL (Stony Brook; New York City, NY, USA). Anticancer Res 37:3983-3990, 2017.
Clinicopathological and Corresponding Genetic Features of Colorectal Signet Ring Cell Carcinoma. K. TAJIRI, T. SUDOU, F. FUJITA, T. HISAKA, T. KINUGASA, Y. AKAGI (Fukuoka, Japan). Anticancer Res 37:3817-3824, 2017.
Clinical Implications of Augmenter of Liver Regeneration in Cancer: A Systematic Review. K.H. NGUYEN, A.H. NGUYEN, D.V. DABIR (Los Angeles, CA, USA). Anticancer Res 37:3379-3384, 2017.
Application of Cancer Cell Reprogramming Technology to Human Cancer Research.  X.-Y. PAN, M.-H. TSAI, K. WUPUTRA, C.-C. KU, W.-H. LIN, Y.-C. LIN, S. KISHIKAWA, M. NOGUCHI, S. SAITO, C.-S. LIN, K.K. YOKOYAMA (Hanzhou, PR China; Kaohsiung, Taiwan, ROC; Tsukuba; Yaita; Tokyo; Sanuki, Japan). Anticancer Res 37:3367-3378, 2017.
Desmoid Tumors in Familial Adenomatous Polyposis. M.L. DE MARCHIS, F. TONELLI, D. QUARESMINI, D. LOVERO, D. DELLA-MORTE, F. SILVESTRIS, F. GUADAGNI, R. PALMIROTTA (Rome; Florence; Bari, Italy). Anticancer Res 37:3357-3366, 2017.
Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability. E. VIRGILIO, A. PROIETTI, R. D’URSO, P. CARDELLI, E. GIARNIERI, M. MONTAGNINI, M.R. GIOVAGNOLI, P. MERCANTINI, G. BALDUCCI, M. CAVALLINI (Rome, Italy). Anticancer Res 37:2817-2822,2017.
Page: 1 2 3 4 5 6 ... 7 8 9 10 11 12 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system